Skip to Main Content

INFORMATION FOR

Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)

Conditions

Diseases of the Cardiovascular System

Phase III

What is the purpose of this trial?

PACeS is a trial to study most effective treatment for patients who may experience atrial fibrillation after cardiac surgery, particularly coronary artery bypass grafting (CABG). Atrial fibrillation, or Afib (AF), is an irregular heart rhythm. In some cases, AF can cause blood clots. There are currently 2 classes of drugs for preventing blood clots in patients with AF. Antiplatelets, like aspirin, and anticoagulants, or blood thinners. This study aims to determine whether the addition of blood thinners to antiplatelets will improve treatment outcomes in patients who develop AF after CABG.

  • Trial with
    Icahn School of Medicine at Mount Sinai (ISMMS)
  • Start Date
    03/01/2021
  • End Date
    12/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/15/2022
  • Study HIC
    #2000027269